Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors

The gastrointestinal hormone ghrelin reduces energy expenditure and stimulates food intake. Ghrelin analogs are a possible treatment against cancer anorexia-cachexia syndrome (CACS). This study aimed to investigate whether oral treatment with the non-peptidergic ghrelin receptor agonist HM01 counter...

Full description

Saved in:
Bibliographic Details
Published in:Int J Mol Sci
Main Authors: Villars, Fabienne O., Pietra, Claudio, Giuliano, Claudio, Lutz, Thomas A., Riediger, Thomas
Format: Artigo
Language:Inglês
Published: MDPI 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5454899/
https://ncbi.nlm.nih.gov/pubmed/28475119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18050986
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items